
According to the Spanish news agency EFE on February 20th, Australian authorities have confirmed the arrest of a Chinese citizen suspected of smuggling tobacco into North Korea. The US government believes this activity is linked to illicitly funding North Korea's nuclear weapons and ballistic missile programs.
The man has been identified by the media as Jin Guanghua. He was requested to be arrested by US authorities in Melbourne on March 21, 2023.
Currently, the 52-year-old businessman is being detained in Australia, awaiting extradition to the United States for trial in a criminal court. He faces a series of charges, including "bank fraud, money laundering, conspiracy," the agency added in a brief statement.
US authorities have claimed that Jho Low and his two partners transferred over $84 million to North Korea through a series of companies registered in the UK, New Zealand, the UAE, and China.
According to the Federal Bureau of Investigation (FBI), the money eventually flowed to a military company and a government agency in North Korea, with the two entities reportedly earning approximately $70 billion over a decade.
So far, American authorities have only arrested Jin Guanghua, who founded a company in Melbourne in 2021, but they are still searching for his two partners: Han Linlin and Qin Guoming, aged 42 and 50 respectively.
In April 2023, US authorities fined British American Tobacco and one of its subsidiaries a total of $630 million for bank fraud, violating sanctions against Pyongyang, and illegally selling cigarettes to North Korea from 2007 to 2017.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.